GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haw Par Corp Ltd (OTCPK:HAWPY) » Definitions » Price-to-Owner-Earnings

Haw Par (Haw Par) Price-to-Owner-Earnings : 9.91 (As of May. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Haw Par Price-to-Owner-Earnings?

As of today (2024-05-06), Haw Par's share price is $28.64. Haw Par's Owner Earnings per Share (TTM) ended in Dec. 2023 was $2.89. It's Price-to-Owner-Earnings for today is 9.91.


The historical rank and industry rank for Haw Par's Price-to-Owner-Earnings or its related term are showing as below:

HAWPY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.47   Med: 16.93   Max: 25.09
Current: 9.9

During the past 13 years, the highest Price-to-Owner-Earnings of Haw Par was 25.09. The lowest was 8.47. And the median was 16.93.


HAWPY's Price-to-Owner-Earnings is ranked better than
88.07% of 419 companies
in the Drug Manufacturers industry
Industry Median: 28.28 vs HAWPY: 9.90

As of today (2024-05-06), Haw Par's share price is $28.64. Haw Par's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.92. Therefore, Haw Par's PE Ratio for today is 9.80.

As of today (2024-05-06), Haw Par's share price is $28.64. Haw Par's EPS without NRI for the trailing twelve months (TTM) ended in was $2.92. Therefore, Haw Par's PE Ratio without NRI for today is 9.80.

During the past 13 years, Haw Par's highest PE Ratio without NRI was 25.18. The lowest was 8.46. And the median was 16.72.


Haw Par Price-to-Owner-Earnings Historical Data

The historical data trend for Haw Par's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haw Par Price-to-Owner-Earnings Chart

Haw Par Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.20 17.81 23.63 14.59 10.01

Haw Par Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.63 - 14.59 - 10.01

Competitive Comparison of Haw Par's Price-to-Owner-Earnings

For the Drug Manufacturers - General subindustry, Haw Par's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haw Par's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haw Par's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Haw Par's Price-to-Owner-Earnings falls into.



Haw Par Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Haw Par's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=28.64/2.89
=9.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haw Par  (OTCPK:HAWPY) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Haw Par Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Haw Par's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Haw Par (Haw Par) Business Description

Traded in Other Exchanges
Address
401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, and Others segment. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates a majority of its revenue from the ASEAN countries.

Haw Par (Haw Par) Headlines

From GuruFocus

Singapore Based Haw Par Selling at a Discount to NAV

By Holmes Osborne, CFA Holmes Osborne, CFA 07-26-2016

Haw Par Stock Is Believed To Be Significantly Overvalued

By GF Value GF Value 03-31-2021

First Eagle Comments on Haw Par

By Holly LaFon Holly LaFon 04-24-2018